Cristina
Burgui Alcaide
Colaboradora Clínica
Publicaciones (27) Publicaciones de Cristina Burgui Alcaide
2024
2023
-
Assessment of Knowledge and Attitudes Over Time in Postacute COVID-19 Environments: Protocol for an Epidemiological Study
JMIR Research Protocols, Vol. 12, Núm. 1
-
Comparison of the Risk of Hospitalization and Severe Disease Among Co-circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variants
The Journal of infectious diseases, Vol. 227, Núm. 3, pp. 332-338
-
Effect of COVID-19 vaccination on the SARS-CoV-2 transmission among social and household close contacts: A cohort study
Journal of Infection and Public Health, Vol. 16, Núm. 3, pp. 410-417
-
Effectiveness of hepatitis C antiviral treatment and feasibility of hepatitis C elimination goal
Postgraduate Medicine, Vol. 135, Núm. 4, pp. 352-360
-
Infecciones, hospitalizaciones y mortalidad por COVID-19 en Navarra entre febrero de 2020 y septiembre de 2022
Anales del sistema sanitario de Navarra, Vol. 46, Núm. 2, pp. 61-70
-
Infección, hospitalización y mortalidad por COVID-19 en Navarra, febrero de 2020 a septiembre de 2022
Anales del sistema sanitario de Navarra, Vol. 46, Núm. 1
-
Patient satisfaction with HIV care service in Spain: results from a cross-sectional patient survey
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 35, Núm. 6, pp. 892-898
-
Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 5
-
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 47
-
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 47
2022
-
Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants
Microbiology Spectrum, Vol. 10, Núm. 2
-
Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 27, Núm. 26
-
Epidemiologic Features and Control Measures during Monkeypox Outbreak, Spain, June 2022
Emerging Infectious Diseases, Vol. 28, Núm. 9, pp. 1847-1851
-
Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022
Eurosurveillance, Vol. 27, Núm. 33
-
Transmission of SARS-CoV-2 infection and risk factors in a cohort of close contacts
Postgraduate Medicine, Vol. 134, Núm. 2, pp. 230-238
2021
-
Effect of influenza vaccination in patients with asthma
CMAJ, Vol. 193, Núm. 29, pp. E1120-E1127
-
Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021
Eurosurveillance, Vol. 26, Núm. 21
-
Hypertension and related comorbidities as potential risk factors for covid-19 hospitalization and severity: A prospective population-based cohort study
Journal of Clinical Medicine, Vol. 10, Núm. 6, pp. 1-12
-
Independent Role of Severe Obesity as a Risk Factor for COVID-19 Hospitalization: A Spanish Population-Based Cohort Study
Obesity, Vol. 29, Núm. 1, pp. 29-37